Ectin Research
Our novel therapy for eliminating cancer tumors, MFA370, will be tested in clinical trials on metastatic bladder cancer. Preclinical studies have shown positive results in inducing cell death in breast, colorectal and prostate cancer cells too. MFA370 is planned to be a simple oral tablet with few if any side effects. It is a combination of two safe, standard, well-established pharmaceuticals that have already undergone large-scale clinical trials.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Ectin Research
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Ectin Research
1 distinct titles indexed · top 1 shown.
- 1board member
Sign up to unlock all 1 contacts at Ectin Research
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Ectin Research
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.